Mark Roschewski, MD
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
Conditions I Treat
- Lymphoma
- B cell lymphoma
- Burkitt lymphoma
Get to Know Me
I’m a hematologist-oncologist at Memorial Sloan Kettering Cancer Center (MSK) who has special training in treating lymphoma. Lymphoma is a type of cancer that starts in the white blood cells that help the body fight infection.
I am an expert in treating aggressive B-cell lymphomas. This includes diffuse large B-cell lymphoma, Burkitt’s lymphoma, and lymphomas that have spread to the central nervous system. I see patients at Memorial Hospital, which is MSK’s main hospital, and at the David H. Koch Center for Cancer Care at MSK.
Facing a cancer diagnosis requires making many important decisions. You need a team that offers support and empathy to help you navigate this difficult time. As a doctor, I combine expert medical knowledge with care that is focused on the patient.
I believe in open and honest communication. I help my patients understand their diagnosis and treatment options. We make decisions together based on your personal goals. My goal is to work with you to choose treatments that give the best results while reducing long-term side effects.
I also work on clinical trials for lymphoma. This keeps me up to date on the latest research. It also allows me to offer my patients newer treatments that might not be available at other hospitals.
I became a doctor because I value the special bond between a patient and their doctor. I started my career at the Walter Reed Army Medical Center as an active-duty physician. After serving on active duty for 12 years, I joined the U.S. Public Health Service (USPHS) and was part of the faculty at the National Cancer Institute until 2025. I retired from USPHS as a Captain in 2023.
My research focuses on blood tests that look for circulating tumor DNA, which is DNA shed from cancer cells into the blood. This helps us create more targeted therapies for patients.
Outside of work, I am a trained singer. I also enjoy playing golf and traveling with my family.
I'm a lymphoma specialist, which is a doctor with special training in diagnosing and treating lymphoma (lim-FOH-muh). This cancer starts in the cells of the immune system.
- Attending Physician
Conditions I Treat
- Lymphoma
- B cell lymphoma
- Burkitt lymphoma
- Central nervous system (CNS) lymphoma
Education
- Bachelor of Arts, University of Notre Dame
- MD, University of Nebraska Medical Center
Residencies
- Internal Medicine, Dwight D. Eisenhower Army Medical Centers
Fellowships
- Hematology-Oncology, Walter Reed National Military Medical Center
Board Certifications
- Internal Medicine
- Oncology
- Hematology
Awards and Honors
- Tech Transfer Award, Center for Cancer Research (2024)
- Top 5 Abstract Award LRF Workshop on Mantle Cell Lymphoma (2021)
- Top Advances at the Center for Cancer Research (2020)
- Researcher of the Year, U.S. Public Health Service (2017)
- Presidential Unit Citation Award (2015)
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, EPO PPO, POS, Transplant
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
Supplemental
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
POS, EPO, HMO
In Network Coverage Type
State Government
In Network Coverage Type
State Government
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
State Government
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO EPO
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
TBD
In Network Coverage Type
PPO, POS, EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
HMO
City Employee Health Plans (Gold and Gold Care)
In Network Coverage Type
Supplemental
In Network Coverage Type
PPO/OAP
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO/EPO
In Network Coverage Type
PPO, EPO
In Network Coverage Type
State Government
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO, POS
In Network Coverage Type
PPO, POS, HMO
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
- Roschewski M, Kurtz DM, Westin JR, Lynch RC, Gopal AK, Alig SK, Sworder BJ, Cherng HJ, Kuffer C, Blair D, Brown K, Goldstein JS, Schultz A, Close S, Chabon JJ, Diehn M, Wilson WH, Alizadeh AA. Remission Assessment by Circulating Tumor DNA in Large B-Cell Lymphoma. J Clin Oncol. 2025 Dec;43(34):3652-3661. Epub 2025 Aug 13. PMID: 40802906; PMCID: PMC12363663.
- Melani C, Lakhotia R, Pittaluga S, Phelan JD, Huang DW, Wright G, Simard J, Muppidi J, Thomas CJ, Ceribelli M, Tosto FA, Yang Y, Xu W, Davies-Hill T, Pack SD, Peer CJ, Arisa O, Mena E, Lindenberg L, Bergvall E, Portell CA, Farah RJ, Lee ST, Pradhan A, Morrison C, Tadese A, Juanitez AM, Lu C, Jacob A, Simmons H, Figg WD, Steinberg SM, Jaffe ES, Roschewski M, Staudt LM, Wilson WH. Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma. N Engl J Med. 2024 Jun 20;390(23):2143-2155. PMID: 38899693; PMCID: PMC11192235.
- Melani C, Lakhotia R, Pittaluga S, Phelan JD, Huang DW, Wright G, Simard J, Muppidi J, Thomas CJ, Ceribelli M, Tosto FA, Yang Y, Xu W, Davies-Hill T, Pack SD, Peer CJ, Arisa O, Mena E, Lindenberg L, Bergvall E, Portell CA, Farah RJ, Lee ST, Pradhan A, Morrison C, Tadese A, Juanitez AM, Lu C, Jacob A, Simmons H, Figg WD, Steinberg SM, Jaffe ES, Roschewski M, Staudt LM, Wilson WH. Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma. N Engl J Med. 2024 Jun 20;390(23):2143-2155. PMID: 38899693; PMCID: PMC11192235.
- Roschewski M, Staudt LM, Wilson WH. Burkitt’s Lymphoma. N Engl J Med. 2022 Sep 22;387(12):1111-1122. PMID: 36129999.
- Roschewski M, Dunleavy K, Abramson JS, Powell BL, Link BK, Patel P, Bierman PJ, Jagadeesh D, Mitsuyasu RT, Peace D, Watson PR, Hanna WT, Melani C, Lucas AN, Steinberg SM, Pittaluga S, Jaffe ES, Friedberg JW, Kahl BS, Little RF, Bartlett NL, Fanale MA, Noy A, Wilson WH. Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma. J Clin Oncol. 2020 Aug 1;38(22):2519-2529. Epub 2020 May 26. PMID: 32453640; PMCID: PMC7392744.
- Roschewski M, Dunleavy K, Pittaluga S, Moorhead M, Pepin F, Kong K, Shovlin M, Jaffe ES, Staudt LM, Lai C, Steinberg SM, Chen CC, Zheng J, Willis TD, Faham M, Wilson WH. Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study. Lancet Oncol. 2015 May;16(5):541-9. Epub 2015 Apr 1. Erratum in: Lancet Oncol. 2015 May;16(5):e199. PMID: 25842160; PMCID: PMC4460610.
Visit PubMed for a full listing of Dr. Roschewski’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.